| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2025―Okt―16 |
Drug-related problems, adverse drug reactions, and drug-drug interactions as a result of a pandemic that took us by surprise: COVID-19 in Mexico |
Ivo Heyerdahl-Viau, Carlos Olaf Sánchez-German, Armando Gómez-Sánchez, Francisco Javier Prado-Galbarro, Mireya García-Casas, Alfonso Mata-Bermudez, Juan Manuel Martínez-Núñez |
| 2 |
[GO] |
2025―Feb―15 |
Potential drug interactions with nirmatrelvir/ritonavir in critically ill patients with COVID-19 - a retrospective observational study |
Dominik Jarczak, Christina König, Anka C Röhr, Anika Forstreuter, Thomas Theo Brehm, Julian Schulze zur Wiesch, et al. (+3) Kevin Roedl, Stefan Kluge, Marlene Fischer |
| 3 |
[GO] |
2024―Nov―01 |
A clinical study to detect COVID-19 infection from a non-invasive breath sample |
Stephen Winchester, Jonathan Rowles, Linda Pomeroy, Alexander Chapovsky, Boris Gorbunov, Joshua John, et al. (+2) Kashif Jabbar, Isaac John |
| 4 |
[GO] |
2024―Jan―08 |
PREDICTION OF NEW LIKELY EMERGENT AMINO ACID POINT MUTATIONS FROM USA, UK, ITALY, FRANCE, BRAZIL AND INDIA SARS-CoV-2 VARIANTS: A POSSIBLE SOURCE FOR MORE RELIABLE COCKTAIL CORONAVIRUS VACCINE |
Saganuwan Alhaji Saganuwan |
| 5 |
[GO] |
2023―Aug―08 |
Mutation Of Amino Acids In Sars-Cov-2 May Be Responsible For Cov-2 Vaccine Long Term Inefficiency |
Saganuwan Alhaji Saganuwan |
| 6 |
[GO] |
2023―Jun―09 |
Protection of SARS-CoV-2 trial vaccines in human is a function of the viral genomes |
Saganuwan Alhaji Saganuwan |
|
